Search Results - "Christofides, Anthos"

Refine Results
  1. 1

    The role of peroxisome proliferator-activated receptors (PPAR) in immune responses by Christofides, Anthos, Konstantinidou, Eirini, Jani, Chinmay, Boussiotis, Vassiliki A.

    Published in Metabolism, clinical and experimental (01-01-2021)
    “…Peroxisome proliferator-activated receptors (PPARs) are fatty acid-activated transcription factors of nuclear hormone receptor superfamily that regulate energy…”
    Get full text
    Journal Article
  2. 2

    Targeted deletion of PD-1 in myeloid cells induces antitumor immunity by Strauss, Laura, Mahmoud, Mohamed A A, Weaver, Jessica D, Tijaro-Ovalle, Natalia M, Christofides, Anthos, Wang, Qi, Pal, Rinku, Yuan, Min, Asara, John, Patsoukis, Nikolaos, Boussiotis, Vassiliki A

    Published in Science immunology (03-01-2020)
    “…PD-1, a T cell checkpoint receptor and target of cancer immunotherapy, is also expressed on myeloid cells. The role of myeloid-specific versus T cell-specific…”
    Get more information
    Journal Article
  3. 3

    Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2 by Christofides, Anthos, Karantanos, Theodoros, Bardhan, Kankana, Boussiotis, Vassiliki A

    Published in Oncotarget (20-12-2016)
    “…Polycomb group proteins regulate chromatin structure and have an important regulatory role on gene expression in various cell types. Two polycomb group…”
    Get full text
    Journal Article
  4. 4

    Regulation of T Cell Differentiation and Function by EZH2 by Karantanos, Theodoros, Chistofides, Anthos, Barhdan, Kankana, Li, Lequn, Boussiotis, Vassiliki A

    Published in Frontiers in immunology (03-05-2016)
    “…The enhancer of zeste homolog 2 (EZH2), one of the polycomb-group proteins, is the catalytic subunit of Polycomb-repressive complex 2 (PRC2) and induces the…”
    Get full text
    Journal Article
  5. 5

    Critical Role of IL-8 Targeting in Gliomas by Kosmopoulos, Marinos, Christofides, Anthos, Drekolias, Dimitrios, Zavras, Phaedon D, Gargalionis, Antonios N, Piperi, Christina

    Published in Current medicinal chemistry (01-01-2018)
    “…Glioma is a heterogeneous, highly complicated central nervous system (CNS) tumor with uncertain mechanism of initiation and progression, resulting in an…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Structural, biochemical, and functional properties of the Rap1-Interacting Adaptor Molecule (RIAM) by Sari-Ak, Duygu, Torres-Gomez, Alvaro, Yazicioglu, Yavuz-Furkan, Christofides, Anthos, Patsoukis, Nikolaos, Lafuente, Esther M, Boussiotis, Vassiliki A

    Published in Biomedical Journal (01-04-2022)
    “…Leukocytes, the leading players of immune system, are involved in innate and adaptive immune responses. Leukocyte adhesion to endothelial cells during…”
    Get full text
    Journal Article
  8. 8

    Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications by Pneumaticos, Spyros G, Christofides, Anthos, Gkioka, Eliona, Kalogeropoulos, Theodoros, Msaouel, Pavlos, Koutsilieris, Michael

    Published in Expert opinion on therapeutic targets (01-12-2013)
    “…Osteoprotegerin (OPG) acts as a soluble decoy receptor for the bone marrow stroma cell-derived and osteoblast-derived receptor activator of nuclear factor-kB…”
    Get more information
    Journal Article
  9. 9

    The complex role of tumor-infiltrating macrophages by Christofides, Anthos, Strauss, Laura, Yeo, Alan, Cao, Carol, Charest, Alain, Boussiotis, Vassiliki A.

    Published in Nature immunology (01-08-2022)
    “…Long recognized as an evolutionarily ancient cell type involved in tissue homeostasis and immune defense against pathogens, macrophages are being re-discovered…”
    Get full text
    Journal Article
  10. 10

    Targeted Deletion of Pparβ/δ in Myeloid Cells Enhances Their Tumor-Promoting Function by Christofides, Anthos, Pal, Rinku, Patsoukis, Nikolaos, Boussiotis, Vassiliki A

    Published in Blood (02-11-2023)
    “…Peroxisome proliferator activated receptors (PPARs) are transcription factors of the nuclear hormone transcription superfamily. Thee different PPAR subtypes…”
    Get full text
    Journal Article
  11. 11

    Pathophysiological mechanisms regulated by cytokines in gliomas by Christofides, Anthos, Kosmopoulos, Marinos, Piperi, Christina

    Published in Cytokine (Philadelphia, Pa.) (01-02-2015)
    “…•Cytokine deregulation characterizes gliomas.•IL-18 links glioma formation to microglial inflammation.•TNF family members mediate tumor growth.•IL-8, IL-6 and…”
    Get full text
    Journal Article
  12. 12

    RIAM regulates myeloid cell fate commitment and macrophage polarization and controls tumor progression by Christofides, Anthos, Cao, Carol, Pal, Rinku, Boussiotis, Vassiliki A

    Published in The Journal of immunology (1950) (01-05-2021)
    “…Abstract Initiation of immune responses requires integrin-mediated adhesion between T cells and APC, linking innate and adaptive immunity. Integrins also…”
    Get full text
    Journal Article
  13. 13

    Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression by Yeo, Alan T., Rawal, Shruti, Delcuze, Bethany, Christofides, Anthos, Atayde, Agata, Strauss, Laura, Balaj, Leonora, Rogers, Vaughn A., Uhlmann, Erik J., Varma, Hemant, Carter, Bob S., Boussiotis, Vassiliki A., Charest, Al

    Published in Nature immunology (01-06-2022)
    “…Glioblastoma (GBM) is an incurable primary malignant brain cancer hallmarked with a substantial protumorigenic immune component. Knowledge of the GBM immune…”
    Get full text
    Journal Article
  14. 14

    Pparβ/δ Has an Indispensable Role in T Cell Function and Anti-Tumor Responses by Ibis, Betul, Christofides, Anthos, Aliazis, Konstantinos, Shah, Rushil, Pal, Rinku, Boussiotis, Vassiliki A

    Published in Blood (02-11-2023)
    “…The peroxisome proliferator-activated receptors (PPARs) are a group of transcriptional factor of the nuclear hormone receptor superfamily, which promote…”
    Get full text
    Journal Article
  15. 15

    PD-1 Expression By Dendritic Cells Is a Key Regulator of T-Cell Immunity in Cancer by Shah, Rushil, Aliazis, Konstantinos, Christofides, Anthos, Pham, Angelique A, Pal, Rinku, Boussiotis, Vassiliki A

    Published in Blood (02-11-2023)
    “…Programmed cell death 1 (PD-1) is an inhibitory receptor expressed on a variety of immune cells and a therapeutic target of checkpoint immunotherapy for cancer…”
    Get full text
    Journal Article
  16. 16

    Specific PD-1 Deletion on Regulatory T Cells Leads to Enhanced Anti-Tumor Responses by Aliazis, Konstantinos, Christofides, Anthos, Aksoylar, Halil-Ibrahim, Shah, Rushil, Pal, Rinku, Patsoukis, Nikolaos, Boussiotis, Vassiliki A

    Published in Blood (02-11-2023)
    “…Programmed cell death 1 (PD-1) is a T cell inhibitory receptor and the most extensively exploited therapeutic target of checkpoint immunotherapy in cancer…”
    Get full text
    Journal Article
  17. 17

    Immune cellular components and signaling pathways in the tumor microenvironment by Yenyuwadee, Sasitorn, Aliazis, Konstantinos, Wang, Qi, Christofides, Anthos, Shah, Rushil, Patsoukis, Nikolaos, Boussiotis, Vassiliki A.

    Published in Seminars in cancer biology (01-11-2022)
    “…During the past decade there has been a revolution in cancer therapeutics by the emergence of antibody-based and cell-based immunotherapies that modulate…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Loss of the nuclear receptor PPARγ primes CD8+ T cells for exhaustion by Shah, Rushil, Christofides, Anthos, Aksoylar, Halil-Ibrahim, Pal, Rinku, Boussiotis, Vassiliki A, Patsoukis, Nikolaos

    Published in The Journal of immunology (1950) (01-05-2022)
    “…Abstract Peroxisome proliferator activated receptors (PPARs) are transcription factors that belong to nuclear hormone superfamily, with three distinct types…”
    Get full text
    Journal Article